Tate & Lyle Enter Monk Fruit Sweetener Business
The company has obtained exclusive marketing and distribution rights for BioVittoria Ltd.’s monk fruit extract and will brand it as PureFruit monk fruit sweetener.
Ingredient supplier Tate & Lyle (Decatur, IL) has obtained exclusive marketing and distribution rights for BioVittoria Ltd.’s (Hamilton, New Zealand) monk fruit extract, an ingredient that Tate & Lyle is branding as PureFruit monk fruit sweetener.
BioVittoria, a company specializing in monk fruit extract, will continue to cultivate and process the ingredient.
Tate & Lyle’s move comes at a time when interest in natural sweeteners, like stevia and monk fruit, is at an all-time high. “In addition to its great taste, PureFruit enables a ‘sweetened with fruit extract’ label claim, which our research shows is extremely appealing to consumers,” said Karl Kramer, Tate & Lyle president of innovation and commercial development.
The PureFruit sweetener can be applied to a variety of foods, including beverages, cereal, confectionery, and bakery products.
Also known as luo han guo, monk fruit is believed to have been used in Asia for hundreds of years. The fruit produces a calorie-free sweetener that is estimated at somewhere near 200 times the sweetness of sugar. The extract received Generally Recognized as Safe (GRAS) status from FDA in January 2010.
Polyphenols: The next generation of prebiotics is ready for liftoff
April 21st 2025Explore the prebiotic health benefits of polyphenols and the positive impact they may have on digestive and immune health. Polyphenols, such as those found in European black elderberry, may be an ideal solution for manufacturers trying to break into the digestive health space.
The Nutritional Outlook Podcast Episode 39: Nutritional Outlook's Ingredients to Watch in 2025
February 25th 2025In this episode, Nutritional Outlook interviews Scott Dicker, market insights director from market researcher SPINS, about ingredients and product categories nutraceutical and nutrition product manufacturers should watch in 2025.
